Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin successfully treated with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage

A case of ureteral obstruction and sepsis induced by bladder perforation following intravesical... We report a case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin (BCG) that was successfully treated non-surgically. A 56-year-old man was diagnosed with non-muscle invasive bladder cancer. He was treated with intravesical BCG instillation after transurethral resection of the bladder tumor. Just before the 6th course of intravesical BCG, the patient was diagnosed with bladder perforation and developed ureteral obstruction and sepsis associated with BCG. He was treated successfully with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage. Bladder perforation associated with BCG is a very rare adverse event that causes severe sepsis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Cancer Conference Journal Springer Journals

A case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin successfully treated with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage

Download PDF
4 pages

Loading next page...
 
/lp/springer_journal/a-case-of-ureteral-obstruction-and-sepsis-induced-by-bladder-mV0l8J6hL8
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Japan Society of Clinical Oncology
Subject
Medicine & Public Health; Oncology; Surgical Oncology
eISSN
2192-3183
DOI
10.1007/s13691-018-0331-4
Publisher site
See Article on Publisher Site

Abstract

We report a case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin (BCG) that was successfully treated non-surgically. A 56-year-old man was diagnosed with non-muscle invasive bladder cancer. He was treated with intravesical BCG instillation after transurethral resection of the bladder tumor. Just before the 6th course of intravesical BCG, the patient was diagnosed with bladder perforation and developed ureteral obstruction and sepsis associated with BCG. He was treated successfully with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage. Bladder perforation associated with BCG is a very rare adverse event that causes severe sepsis.

Journal

International Cancer Conference Journal – Springer Journals

Published: May 31, 2018

References

  • Intravesical bacillus Calmette–Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity
    Böhle, A; Jocham, D; Bock, PR
  • Can intravesical bacillus Calmette–Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis
    Pan, J; Liu, M; Zhou, X
  • Maintenance therapy with bacillus Calmette–Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer
    Hinotsu, S; Akaza, H; Naito, S
  • Side effects of Bacillus Calmette–Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG
    Brausi, M; Oddens, J; Sylvester, R
  • Maintenance Bacillus Calmette-increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial
    Meijden, AP; Sylvester, RJ; Oosterlinck, W
  • Bacillus Calmette–Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature
    Pérez-Jacoiste Asín, MA; Fernández-Ruiz, M; López-Medrano, F
  • Short term complications from transurethral resection of bladder tumor
    Gregg, JR; McCormick, B; Wang, L
  • Non-traumatic bladder rupture showing less than 10 Hounsfield units of ascites
    Mizumura, N; Okumura, S; Toyoda, S
  • Intraperitoneal urinary bladder perforation with pneumoperitoneum in association with indwelling Foley Catheter diagnosed in emergency department
    Zhan, C; Maria, PP; Dym, RJ
  • Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant!
    Fazlioglu, A; Tandogdu, Z; Kurtulus, FO; Parlakkilic, O; Cek, M
  • Bladder perforation after immediate postoperative intravesical instillation of mitomycin C
    Lim, D; Izawa, JI; Middlebrook, P; Chin, JL
  • Complications of intravesical therapy for urothelial cancer of the bladder
    Koya, MP; Simon, MA; Soloway, MS
  • Treatment of tuberculosis guidelines
  • Consensus statement on bladder injuries
    Gomez, RG; Ceballos, L; Coburn, M; Corriere, JN; Dixon, CM; Lobel, B; McAninch, J
  • Outcomes of iatrogenic genitourinary injuries during colorectal surgery
    Eswara, JR; Raup, VT; Potretzke, AM; Hunt, SR; Brandes, SB